Cargando…

ARRB1 enhances the chemosensitivity of lung cancer through the mediation of DNA damage response

ARRB1 (also known as β-arrestin-1) serves as a multifunctional adaptor contributing to the regulation of signaling pathways. ARRB1 may be involved in DNA damage accumulation; however the underlying mechanism involved is unclear. In the present study, non-small cell lung cancer (NSCLC) cell lines (H5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Hongchang, Wang, Liguang, Zhang, Jiangang, Dong, Wei, Zhang, Tiehong, Ni, Yang, Cao, Hongxin, Wang, Kai, Li, Yun, Wang, Yibing, Du, Jiajun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355695/ https://www.ncbi.nlm.nih.gov/pubmed/28035404 http://dx.doi.org/10.3892/or.2016.5337

Ejemplares similares

The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies
por: Zhu, Linhai, et al.
Publicado: (2016)

Effects of postoperative non-steroidal anti-inflammatory drugs on long-term survival and recurrence of patients with non-small cell lung cancer
por: Jiang, Wensheng, et al.
Publicado: (2018)

Predictive Effects of Lung function test on Postoperative Pneumonia in Squamous Esophageal Cancer
por: Wei, Ran, et al.
Publicado: (2016)

Subcellular localization of β-arrestin1 and its prognostic value in lung adenocarcinoma
por: Li, Xiaowei, et al.
Publicado: (2017)

Regulation of response to radiotherapy by β-arrestin1 in Non-small cell lung cancer
por: Wang, Liguang, et al.
Publicado: (2019)

Evaluation of Preoperative Hematologic Markers as Prognostic Factors and Establishment of Novel Risk Stratification in Resected pN0 Non-Small-Cell Lung Cancer
por: Zhang, Tiehong, et al.
Publicado: (2014)

Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis
por: Ye, Yingquan, et al.
Publicado: (2022)

Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis
por: Shen, Hongchang, et al.
Publicado: (2017)

The Comprehensive Analysis of Hub Gene ARRB2 in Prostate Cancer
por: Zhou, Bing, et al.
Publicado: (2022)

Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort
por: Sun, Haifeng, et al.
Publicado: (2015)

Invasion Types Are Associated With Poor Prognosis in Lung Squamous Carcinoma Patients
por: Zhao, Yang, et al.
Publicado: (2015)

Arrb2 promotes endothelial progenitor cell-mediated postischemic neovascularization
por: Wang, Xuelian, et al.
Publicado: (2020)

The Number of Resected Lymph Nodes (nLNs) Combined with Tumor Size as a Prognostic Factor in Patients with Pathologic N0 and Nx Non-Small Cell Lung Cancer
por: Yang, Miaomiao, et al.
Publicado: (2013)

Association between Circulating Levels of IGF-1 and IGFBP-3 and Lung Cancer Risk: A Meta-Analysis
por: Cao, Hongxin, et al.
Publicado: (2012)

Lower Blood Calcium Associates with Unfavorable Prognosis and Predicts for Bone Metastasis in NSCLC
por: Shen, Hongchang, et al.
Publicado: (2012)

Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma
por: Zhang, Tiehong, et al.
Publicado: (2014)

Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma
por: Che, Keying, et al.
Publicado: (2017)

ARRB1/β-arrestin-1 mediates neuroprotection through coordination of BECN1-dependent autophagy in cerebral ischemia
por: Wang, Pei, et al.
Publicado: (2014)

The association of ARRB1 polymorphisms with response to antidepressant treatment in depressed patients
por: Chappell, Kenneth, et al.
Publicado: (2022)

WDR4 promotes the progression and lymphatic metastasis of bladder cancer via transcriptional down-regulation of ARRB2
por: Wang, Guoli, et al.
Publicado: (2023)

ARRB1 Drives Gallbladder Cancer Progression by Facilitating TAK1/MAPK Signaling Activation
por: Zhang, Xudong, et al.
Publicado: (2021)

Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer
por: Cao, Hongxin, et al.
Publicado: (2015)

Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy
por: Qu, Xiao, et al.
Publicado: (2017)

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer
por: Zecchini, Vincent, et al.
Publicado: (2014)

Effect of mu Agonists on Long-Term Survival and Recurrence in Nonsmall Cell Lung Cancer Patients
por: Wang, Kai, et al.
Publicado: (2015)

β-Arrestin 1 (ARRB1) serves as a molecular marker of the peripheral circadian rhythm
por: Tomita, Tatsunosuke, et al.
Publicado: (2019)

Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes
por: Liu, Hongfeng, et al.
Publicado: (2019)

Association between two CHRNA3 variants and susceptibility of lung cancer: a meta-analysis
por: Qu, Xiao, et al.
Publicado: (2016)

ARRB1 Regulates Metabolic Reprogramming to Promote Glycolysis in Stem Cell-Like Bladder Cancer Cells
por: Mamouni, Kenza, et al.
Publicado: (2021)

Mutated DNA Damage Repair Pathways Are Prognostic and Chemosensitivity Markers for Resected Colorectal Cancer Liver Metastases
por: Wang, Kun, et al.
Publicado: (2021)

Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer
por: Zhou, Yang, et al.
Publicado: (2020)

Prognostic Significance of Systemic Inflammation-Based Lymphocyte- Monocyte Ratio in Patients with Lung Cancer: Based on a Large Cohort Study
por: Hu, Pingping, et al.
Publicado: (2014)

An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy
por: Wang, Ying, et al.
Publicado: (2018)

miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer
por: Wang, Tianzhen, et al.
Publicado: (2019)

Molecular docking studies of a-mangostin with oral cancer targets ARRB1, FLNA, CALM3 and HTT
por: Sunitha, Janardhanan, et al.
Publicado: (2020)

Inhibition of NIPBL enhances the chemosensitivity of non-small-cell lung cancer cells via the DNA damage response and autophagy pathway
por: Zheng, Lei, et al.
Publicado: (2018)

Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC
por: Cao, Hongxin, et al.
Publicado: (2016)

AURKA Increase the Chemosensitivity of Colon Cancer Cells to Oxaliplatin by Inhibiting the TP53-Mediated DNA Damage Response Genes
por: Shan, Baocong, et al.
Publicado: (2020)

circITGB1 Regulates Adipocyte Proliferation and Differentiation via the miR-23a/ARRB1 Pathway
por: Yue, Xiaoyv, et al.
Publicado: (2023)

The Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort
por: Ding, Nan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qpbvvkmdaprsiccsfom1m6q2dg